Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with NEUP: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
NEUP
Neuphoria Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
NEUP
Neuphoria Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
NEUP
Neuphoria Therapeutics Inc.
Change
2.80
▲
+1.08%
· post 2.80
Closed
Nov 6 '26
Mkt cap
$15.0M
Revenue
$15M
Q3 FY25
Revenue
—
vs
Compare
Closed
Nov 6 '26
LLY
ELI Lilly & Co
vs
NEUP
Neuphoria Therapeutics Inc.
1,360.90
▼
−0.28%
post 1,358.90
Price
2.80
▲
+1.08%
post 2.80
$1.2T
Mkt cap
$15.0M
Q3 FY26
$24.4B
Revenue
$15M
Q3 FY25
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,360.90
▼
−0.28%
vs
NEUP
2.80
▲
+1.08%
Closed
Nov 6 '26
Co-movers
daily closes
Method
›
Moved together
LLY
with
NEUP
No shared trading history for LLY and NEUP.
Shared co-movers: not yet measured (NEUP).
LLY, solid
NEUP, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes